Qritive makes cancer diagnosis fast, cheap, and accurate. Qritive develops AI-powered solutions that enable histopathologic diagnosis of cancer at scale. Our clinical-decision support system for pathologists unlocks efficiency and quality gain in diagnosis, which results in better patient outcome. It includes AI Modules, an Image Management System platform (Pantheon), and a network of pathologists on-demand for services (annotations, 2nd opinion...) Our digital pathology platform has been used by several healthcare institutions in Singapore, India, Morocco, UAE, and USA, and the results have been presented at various events and journals: USCAP 2023 (deep learning on prostate biopsies), 2022 (Ki-67 on Sarcomas), and 2021 (colorectal malignancies), or Nature Scientific Report.
| Website | https://www.qritive.com |
| Employees | 12 (9 on RocketReach) |
| Founded | 2017 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+10 more
(view full list)
|
| Industry | Software Development, Artificial Intelligence, Data and Analytics, Science and Engineering, Software, Biotechnology, Health Care, Information Technology |
| Keywords | Cancer Diagnosis, Digital Pathology, Oncology Technology, Cancer Diagnostics, Medical Image Analysis, Ai Healthcare, Machine Learning Oncology, Clinical Decision Support, Precision Oncology, Medical Imaging Ai, Healthcare Ai Solutions, Pathology Solutions, Oncology Software, Cancer Screening, Early Cancer Detection |
| Competitors | IBM, Tempus Labs, Inc., Guardant Health, GRAIL, Freenome, PathAI, Aiforia Technologies, CureMetrix, Fritz AI +35 more (view full list) |
Looking for a particular Qritive employee's phone or email?
Bruno Occhipinti is the Chief Executive Officer (CEO) of Qritive.
9 people are employed at Qritive.